CD7 Positive Megakaryocytes: Significance and Utilization in Myelodysplastic Syndromes

被引：0
|
作者：
Aldyab, Mahmoud [1 ]
Chung, Lorene [2 ]
Nazeer, Tipu [2 ]
机构：
[1] Albany Med Ctr, Albany, NY USA
[2] Albany Med Coll, Albany, NY USA
来源：
LABORATORY INVESTIGATION | 2023年 / 103卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1067
引用
收藏
页码：S1087 / S1088
页数：2
相关论文
共 50 条
  • [1] Biological significance of CD7-positive blasts in myelodysplastic syndromes
    Sato, C.
    Tamura, H.
    Yamashita, T.
    Tsuji, T.
    Dan, K.
    Ogata, K.
    [J]. LEUKEMIA RESEARCH, 2007, 31 : S88 - S88
  • [2] Aggressive characteristics of myeloblasts expressing CD7 in myelodysplastic syndromes
    Satoh, Chikako
    Tamura, Hideto
    Yamashita, Taishi
    Tsuji, Takashi
    Dan, Kazuo
    Ogata, Kiyoyuki
    [J]. LEUKEMIA RESEARCH, 2009, 33 (02) : 326 - 331
  • [3] Expression of CD7 in myelodysplastic syndromes (MDS):: Is this a truly prognostic factor?
    Font, Patricia
    Subira, Dolores
    [J]. LEUKEMIA RESEARCH, 2008, 32 (01) : 185 - 186
  • [4] Expression of CD34 by megakaryocytes In myelodysplastic syndromes
    Pellegrini, W
    Facchetti, F
    Marocolo, D
    Pelizzari, AM
    Capucci, A
    Rossi, G
    [J]. HAEMATOLOGICA, 2000, 85 (10) : 1117 - 1118
  • [5] CD34 Expression by Megakaryocytes in Myelodysplastic Syndromes
    Butler, S. L.
    Boonsakan, P.
    Grier, D. D.
    Li, Y.
    Braylan, R. C.
    Al-Quran, S. Z.
    [J]. LABORATORY INVESTIGATION, 2009, 89 : 256A - 256A
  • [6] CD34 Expression by Megakaryocytes in Myelodysplastic Syndromes
    Butler, S. L.
    Boonsakan, P.
    Grier, D. D.
    Li, Y.
    Braylan, R. C.
    Al-Quran, S. Z.
    [J]. MODERN PATHOLOGY, 2009, 22 : 256A - 256A
  • [7] Engineering Naturally Occurring CD7 Negative Cells for the Immunotherapy of CD7 Positive Leukemia
    Freiwan, Abdullah
    Vaidya, Abishek
    Zebley, Caitlin
    Fan, Yiping
    Langfitt, Deanna
    Youngblood, Benjamin
    Mamonkin, Maksim
    Gottschalk, Stephen
    Velasquez, Mireya Paulina
    [J]. BLOOD, 2019, 134
  • [8] CD31 (PECAM1) immunohistochemical stain on megakaryocytes in myelodysplastic syndromes
    Isghi, N. Azrou
    Kassa, R.
    Chilla, D.
    Belarbi, A.
    [J]. VIRCHOWS ARCHIV, 2021, 479 : S250 - S250
  • [9] Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
    Bardet, Valerie
    Wagner-Ballon, Orianne
    Guy, Julien
    Morvan, Celine
    Debord, Camille
    Trimoreau, Franck
    Benayoun, Emmanuel
    Chapuis, Nicolas
    Freynet, Nicolas
    Rossi, Cedric
    Mathis, Stephanie
    Gourin, Marie-Pierre
    Toma, Andrea
    Bene, Marie C.
    Feuillard, Jean
    Guerin, Estelle
    [J]. HAEMATOLOGICA, 2015, 100 (04) : 475 - 481
  • [10] BIOLOGICAL CHARACTERISTICS OF CD7 POSITIVE ACUTE MYELOGENOUS LEUKEMIA
    ETO, T
    AKASHI, K
    HARADA, M
    SHIBUYA, T
    TAKAMATSU, Y
    TESHIMA, T
    NIHO, Y
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (03) : 508 - 514
12345